Does BOTULINUM TOXIN TYPE A Cause Urinary retention? 29 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Urinary retention have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 0.8% of all adverse event reports for BOTULINUM TOXIN TYPE A.
29
Reports of Urinary retention with BOTULINUM TOXIN TYPE A
0.8%
of all BOTULINUM TOXIN TYPE A reports
0
Deaths
6
Hospitalizations
How Dangerous Is Urinary retention From BOTULINUM TOXIN TYPE A?
Of the 29 reports, 6 (20.7%) required hospitalization.
Is Urinary retention Listed in the Official Label?
Yes, Urinary retention is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Urinary retention Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE